Related Experiment Video
Updated: May 7, 2026

Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
Temporal changes in pneumococcal colonization in a rural African community with high HIV prevalence following routine
Susan A Nzenze1, Tinevimbo Shiri, Marta C Nunes
1From the *Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases; †Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa; ‡Department of Global Health, Rollins School of Public Health; and §Division of Infectious Diseases, School of Medicine, Emory University, Atlanta, Georgia; ¶MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; ‖Centre for Global Health Research, Umeå University, Umeå, Sweden; **INDEPTH Network, Accra, Ghana; and ††National Institute for Communicable Diseases, National Health Laboratory Service, Sandringham, South Africa.
Insights
Routine infant pneumococcal conjugate vaccine (PCV) immunization significantly reduced vaccine-type nasopharyngeal colonization in a South African community. This indirect effect was observed within two years, even in a high HIV prevalence setting.
Area of Science:
- Public Health
- Infectious Diseases
- Vaccinology
Background:
- Pneumococcal conjugate vaccine (PCV) immunization in children reduces nasopharyngeal carriage of vaccine-type *Streptococcus pneumoniae*.
- The study investigated the impact of routine infant PCV immunization on pneumococcal colonization in a rural African community with a high prevalence of HIV.
Purpose of the Study:
- To assess the effect of routine infant PCV immunization on the epidemiology of nasopharyngeal pneumococcal colonization.
- To evaluate the indirect impact of PCV on different age groups and the prevalence of non-vaccine serotypes in a high HIV setting.
Main Methods:
- Two cross-sectional surveys were conducted in a rural South African community before and after the introduction of 7-valent PCV (PCV7) in April 2009.
- Nasopharyngeal swabs were collected from household members of randomly selected households with at least one child under two years old.
- Swabs were cultured for *Streptococcus pneumoniae* and serotyped using the Quellung method.
Main Results:
- Overall prevalence of vaccine serotype colonization decreased from 18.3% to 11.4% (P<0.0001) within two years of PCV7 introduction.
- Significant reductions in vaccine serotype colonization were observed across all age groups, including children under 2 years (50% reduction), 6-12 year olds (34% reduction), and adults (64% reduction).
- Prevalence of non-vaccine serotype colonization increased in young children (<2 years) but decreased significantly in adolescents and adults.
Conclusions:
- Routine infant PCV7 immunization demonstrated an indirect protective effect against vaccine serotype colonization within two years in a high HIV prevalence setting.
- The observed decline in non-vaccine serotype colonization among adolescents and adults suggests a potential lag in replacement colonization in these groups.
Background:
Pneumococcal conjugate vaccine (PCV) immunization of children decreases their risk of nasopharyngeal acquisition of vaccine serotypes. We studied the impact of routine infant PCV immunization alone on the epidemiology of nasopharyngeal pneumococcal colonization among a rural African community with high prevalence of HIV positivity.
Methods:
Two cross-sectional surveys were undertaken in a rural South African community from May to October 2009 (period 1) and 2011 (period 2). Seven-valent PCV was introduced into the public immunization program for infants in April 2009, without catch-up campaign for older children. Randomly selected households with at least 1 child<2 years of age were recruited. Nasopharyngeal swabs from all consenting household members were obtained for Streptococcus pneumoniae culture and serotyping by Quellung method.
Results:
The median ages (SD) of children enrolled were 4.32 (SD, 3.4) and 3.80 (SD, 3.4) years in periods 1 and 2, respectively. Overall, the prevalence of vaccine serotype colonization declined from 18.3% (368/2010) in period 1 to 11.4% (418/3659) by period 2 (P<0.0001). This included reductions (adjusted risk ratio) of 50% [95% confidence interval (95% CI): 0.42-0.59], 34% (95% CI: 0.48-0.92) and 64% (95% CI: 0.18-0.74) in age groups<2 years, 6-12 years and adults. The prevalence of vaccine serotype colonization among primary caregivers decreased from 10.2% to 5.4% (P≤0.001) by period 2. The prevalence of nonvaccine serotype colonization increased by 35% (95% CI: 1.17-1.56) among <2-year-old children by period 2, while it declined by 45-54% among adolescents and adults.
Conclusions:
An indirect effect of PCV7 was realized in a high HIV prevalence setting within 2 years of PCV introduction. The unexpected decline in nonvaccine serotypes colonization among adolescents/adults may indicate lag in replacement colonization by nonvaccine serotypes in this group.
More Related Videos
09:12Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
Published on: January 17, 2014
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
Development of Human Microbiota
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Development of the Oral Microbiota
Pneumonia III: Complications and Assessment